XML 22 R11.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 5 - Loan Payable
6 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Debt Disclosure [Text Block]
5.
     LOAN PAYABLE:
 
As of
December
31,
2016,
PA1,
the Company’s wholly-owned subsidiary, owes
$8,679,992
under the terms of the Pennvest Loan related to the construction of the Kreider
1
System including accrued interest and late charges totaling
$925,992.
The terms of the Pennvest Loan provided for funding of up to
$7,754,000
which was to be repaid by interest-only payments for
three
years, followed by an additional
ten
-year amortization of principal. The Pennvest Loan accrues interest at
2.547%
per annum for years
1
through
5
and
3.184%
per annum for years
6
through maturity. The Pennvest Loan required minimum annual principal payments of approximately
$2,001,000
in fiscal years
2013
through
2016,
and
$741,000
in fiscal year
2017,
$760,000
in fiscal year
2018,
$771,000
in fiscal year
2019,
$794,000
in fiscal year
2020,
$819,000
in fiscal year
2021
and
$1,867,000
thereafter. The Pennvest Loan is collateralized by the Kreider
1
System and by a pledge of all revenues generated from Kreider
1
including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider
1
calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of
$49,374
for both of the
three
months ended
December
31,
2016
and
2015,
respectively. The Company has incurred interest expense related to the Pennvest Loan of
$98,747
for both of the
six
months ended
December
31,
2016
and
2015,
respectively. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date,
PA1
commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations,
PA1
has elected not to make interest payments to Pennvest on the Pennvest Loan since
January
2013.
Additionally, the Company has not made any principal payments, which were to begin in fiscal
2013,
and, therefore, the Company has classified the Pennvest Loan as a current liability as of
December
31,
2016.
 
On
September
25,
2014,
Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that
PA1
pay
$8,137,117
(principal, interest plus late charges) on or before
October
24,
2014.
PA1
did not make the payment and does not have the resources to make the payment demanded by Pennvest.
PA1
has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. As of the date of this report, no formal proposals are presently under consideration and only sporadic communication has taken place regarding the matters involved over the past
30
months. It is not possible at this date to predict the outcome of this matter, but the Company believes it is possible that an agreement
may
yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania,
PA1
and Bion will continue to evaluate various options with regard to Kreider
1
over the next
30
-
180
days.
 
In connection with the Pennvest Loan financing documents, the Company provided a ‘technology guaranty’ regarding nutrient reduction performance of Kreider
1
which was structured to expire when Kreider
1’s
nutrient reduction performance had been demonstrated. During
August
2012
the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider
1
System had surpassed the requisite performance criteria and that the Company’s ‘technology guaranty’ was met. As a result, the Pennvest Loan is solely an obligation of
PA1.